Cartiva Synthetic Cartilage Implant
Commercial- Indications
- First metatarsophalangeal joint osteoarthritis, Hallux rigidus
Company intelligence / Profile preview
Cartiva, Inc.
Alpharetta, Georgia, United Statesstryker.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
The Cartiva SCI has demonstrated safety and efficacy as a motion-preserving alternative to fusion in the largest prospective randomized clinical trial for great toe osteoarthritis. It was the first new articular surface material approved by FDA in 18 years and has won multiple clinical research awards. Clinical data show substantial pain reduction with preserved range of motion compared to traditional fusion.
- Therapeutic areas
- Rheumatology
- Modalities
- Synthetic cartilage implant (biomedical polymer)
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Wright Medical Group (prior acquirer)Stryker Corporation (current parent)New Enterprise AssociatesWindham Venture PartnersDomain Associates as investors
Beyond the preview
Go deeper on Cartiva, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cartiva, Inc..